Tech Company Financing Transactions
CyVek Funding Round
CyVek secured a $5.5 million Series D financing round on 2/4/2013. Investors included Connecticut Innovations and private investors.
Transaction Overview
Company Name
Announced On
2/4/2013
Transaction Type
Venture Equity
Amount
$5,500,000
Round
Series D
Investors
Proceeds Purpose
The Series D funding enables the company to create the infrastructure needed to commercialize its novel immunoassay technology, CyPlex(TM), an integrated test system which includes a proprietary microfluidic cartridge that allows the analysis of multiple biomarkers from very small amounts of biological samples.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
2 Barnes Industrial Road South
Wallingford, CT 06492
USA
Wallingford, CT 06492
USA
Phone
Website
Email Address
Overview
The objective of the CyVek technology is to provide a robust platform for multiplexed proteomics, particularly to serve the market needs of biomarker validation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Per Hellsund
Chief Technical Officer
Marty Putnam
VP - Bus. Development
Rajiv Pande
Browse more venture capital transactions:
Prev: 2/4/2013: AllTrails venture capital transaction
Next: 2/5/2013: Coalfire Systems venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs